Monday, February 6, 2023
dental- News
  • Home
  • Dentistry
  • Endodontist
  • Implantology
  • Orthodontics
  • Periodontology
  • Predental
  • Prosthodontics
No Result
View All Result
  • Home
  • Dentistry
  • Endodontist
  • Implantology
  • Orthodontics
  • Periodontology
  • Predental
  • Prosthodontics
HealthNews
No Result
View All Result

Analysts Expect Envista Holdings Co. (NYSE:NVST) Will Post Earnings of $0.44 Per Share

Dental News by Dental News
June 24, 2021
in Prosthodontics
0
Analysts Expect Envista Holdings Co. (NYSE:NVST) Will Post Earnings of $0.44 Per Share
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter


Envista logoWall Street analysts predict that Envista Holdings Co. (NYSE:NVST) will announce earnings of $0.44 per share for the current quarter, Zacks Investment Research reports. Six analysts have provided estimates for Envista’s earnings, with the lowest EPS estimate coming in at $0.41 and the highest estimate coming in at $0.47. Envista reported earnings of ($0.10) per share during the same quarter last year, which indicates a positive year-over-year growth rate of 540%. The business is expected to issue its next earnings report on Thursday, July 29th.

According to Zacks, analysts expect that Envista will report full year earnings of $1.89 per share for the current fiscal year, with EPS estimates ranging from $1.85 to $1.94. For the next fiscal year, analysts anticipate that the business will report earnings of $2.06 per share, with EPS estimates ranging from $1.97 to $2.24. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that cover Envista.

Envista (NYSE:NVST) last posted its earnings results on Wednesday, May 5th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.31 by $0.23. Envista had a return on equity of 6.93% and a net margin of 5.00%.

A number of research analysts have weighed in on NVST shares. Zacks Investment Research raised Envista from a “hold” rating to a “strong-buy” rating and set a $52.00 target price on the stock in a report on Saturday, May 8th. Piper Sandler upped their price target on Envista from $41.00 to $45.00 and gave the stock a “neutral” rating in a research report on Thursday, May 6th. TheStreet upgraded Envista from a “d+” rating to a “c” rating in a research report on Thursday, May 13th. Morgan Stanley increased their target price on Envista from $42.00 to $46.00 and gave the stock an “equal weight” rating in a research report on Friday, May 7th. Finally, Credit Suisse Group increased their price target on Envista from $49.00 to $55.00 and gave the company an “outperform” rating in a research note on Thursday, May 6th. Three investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $43.33.

NVST stock traded up $0.09 during trading on Thursday, reaching $42.94. The stock had a trading volume of 13,407 shares, compared to its average volume of 2,006,693. Envista has a 52 week low of $19.43 and a 52 week high of $46.52. The firm’s 50 day moving average is $43.63. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.77 and a current ratio of 1.02. The company has a market capitalization of $6.90 billion, a price-to-earnings ratio of 63.00, a PEG ratio of 0.90 and a beta of 1.94.

In other Envista news, CEO Amir Aghdaei sold 680 shares of the firm’s stock in a transaction on Friday, March 26th. The stock was sold at an average price of $40.75, for a total transaction of $27,710.00. Following the transaction, the chief executive officer now directly owns 539,870 shares in the company, valued at approximately $21,999,702.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mischa Reis sold 1,049 shares of the firm’s stock in a transaction on Monday, May 3rd. The stock was sold at an average price of $43.73, for a total value of $45,872.77. Following the transaction, the senior vice president now owns 49,159 shares in the company, valued at $2,149,723.07. The disclosure for this sale can be found here. Insiders have sold a total of 207,234 shares of company stock valued at $9,041,951 over the last three months. 0.82% of the stock is owned by corporate insiders.

Hedge funds have recently made changes to their positions in the stock. Victory Capital Management Inc. lifted its position in Envista by 52.6% during the 4th quarter. Victory Capital Management Inc. now owns 29,735 shares of the company’s stock worth $1,003,000 after acquiring an additional 10,245 shares during the period. SG Americas Securities LLC acquired a new stake in Envista during the 4th quarter worth about $658,000. BlackRock Inc. lifted its position in Envista by 1.6% during the 4th quarter. BlackRock Inc. now owns 11,737,717 shares of the company’s stock worth $395,916,000 after acquiring an additional 185,867 shares during the period. Prudential PLC lifted its position in Envista by 12.6% during the 4th quarter. Prudential PLC now owns 10,700 shares of the company’s stock worth $361,000 after acquiring an additional 1,200 shares during the period. Finally, Alliancebernstein L.P. lifted its holdings in shares of Envista by 8.6% in the 4th quarter. Alliancebernstein L.P. now owns 88,910 shares of the company’s stock valued at $2,999,000 after buying an additional 7,070 shares during the period.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company’s Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands.

Further Reading: Diversification Important in Investing

Get a free copy of the Zacks research report on Envista (NVST)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Envista (NYSE:NVST)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured Article: What is a Market Correction?

7 Great Dividend Stocks to Buy For a Comfortable Retirement

There are people who will say the day of set it and forget it retirement accounts are over. But it’s a narrative we’ve heard before. The truth is the formula for saving for and enjoying a comfortable retirement, like the formula for weight loss, hasn’t really changed. A lot depends on whether an individual has the discipline to see it through.

Dividend stocks remain one of the core elements of a retirement portfolio. As individuals near retirement the ability to reinvest dividends allows for a greater total return. And once individuals need to live off their portfolio, the dividends provide a source of income without having to tap their principal.

However, not all dividend stocks are the same and many investors get sucked in by the allure of a high-yield dividend stock. But what you’re really looking for are companies with a history of increasing its dividend. The ability to increase a dividend over time illustrates that the company has a business model that can hold up regardless of how the broader economy is performing.

In this special presentation, we’ll highlight seven stocks that individuals can buy today to capture a stable, recurring dividend.

View the “7 Great Dividend Stocks to Buy For a Comfortable Retirement”.



Source link

Advertisement Banner
Previous Post

Oregon on verge of getting a new type of dentist

Next Post

Graduation 2021: See list of Christian Brothers Academy graduates; meet 2 top students

Dental News

Dental News

Next Post
Graduation 2021: See list of Christian Brothers Academy graduates; meet 2 top students

Graduation 2021: See list of Christian Brothers Academy graduates; meet 2 top students

Discussion about this post

Recommended

Dental Restorative Materials Market to witness an impressive growth during the forecast period 2021 – 2026

Dental Restorative Materials Market to witness an impressive growth during the forecast period 2021 – 2026

2 years ago
An exhibition about a “Generous Dentist”

An exhibition about a “Generous Dentist”

1 year ago

Dental World

Don't Miss

The “oral” history of COVID‐19: Primary infection, salivary transmission, and post‐acute implications – Marchesan – 2021 – Journal of Periodontology

The “oral” history of COVID‐19: Primary infection, salivary transmission, and post‐acute implications – Marchesan – 2021 – Journal of Periodontology

October 11, 2021
Nampa teacher to vie for Miss USA crown – Idaho Press-Tribune

Nampa teacher to vie for Miss USA crown – Idaho Press-Tribune

October 11, 2021
Bio-mechanism Inhibitory Prediction of β-Sitosterol

Perceptions of Dental Undergraduates Towards Online Education During C

October 11, 2021
Clearwater Periodontist says recent studies highlight the safety of dental offices during the COVID-19 pandemic | News

Smile Obsession Grows in Illinois with the Acquisition and Merger of Maplebrook Dental | News

October 11, 2021

Recent News

The “oral” history of COVID‐19: Primary infection, salivary transmission, and post‐acute implications – Marchesan – 2021 – Journal of Periodontology

The “oral” history of COVID‐19: Primary infection, salivary transmission, and post‐acute implications – Marchesan – 2021 – Journal of Periodontology

October 11, 2021
Nampa teacher to vie for Miss USA crown – Idaho Press-Tribune

Nampa teacher to vie for Miss USA crown – Idaho Press-Tribune

October 11, 2021

Categories

  • Dentistry
  • Endodontist
  • Europe
  • Implantology
  • Orthodontics
  • Periodontology
  • Predental
  • Prosthodontics

Follow us

  • Privacy & Policy
  • About Us
  • Contact Us

© 2021 Copyright dental-news

No Result
View All Result
  • Home
  • Dentistry
  • Endodontist
  • Implantology
  • Orthodontics
  • Periodontology
  • Predental
  • Prosthodontics

© 2021 Copyright dental-news